Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)

SHA:603014 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	15,611	16,556	-	-	-	-
Enterprise Value	12,809	13,945	-	-	-	-
Last Close Price	37.37	39.63	-	-	-	-
PE Ratio	30.63	34.33	-	-	-	-
PS Ratio	4.14	4.39	-	-	-	-
PB Ratio	2.19	2.33	-	-	-	-
P/TBV Ratio	2.29	2.42	-	-	-	-
P/FCF Ratio	24.63	26.12	-	-	-	-
P/OCF Ratio	19.67	20.86	-	-	-	-
EV/Sales Ratio	3.40	3.70	-	-	-	-
EV/EBITDA Ratio	15.76	17.48	-	-	-	-
EV/EBIT Ratio	23.00	25.03	-	-	-	-
EV/FCF Ratio	20.21	22.00	-	-	-	-
Debt / Equity Ratio	0	0	0.00	0.00	0.01	0.22
Debt / EBITDA Ratio	0.00	0.00	0.02	0.01	0.08	1.45
Debt / FCF Ratio	0.01	0.01	0.03	0.19	0.10	7.73
Net Debt / Equity Ratio	-0.39	-0.39	-0.20	-0.14	-0.12	0.13
Net Debt / EBITDA Ratio	-3.51	-3.51	-1.57	-1.00	-0.97	0.86
Net Debt / FCF Ratio	-4.42	-4.42	-2.91	-12.82	-1.23	4.52
Asset Turnover	0.48	0.48	0.53	0.54	0.56	-
Inventory Turnover	2.85	2.85	2.52	2.55	3.21	-
Quick Ratio	2.65	2.65	1.59	1.14	1.03	0.61
Current Ratio	3.30	3.30	2.27	1.82	1.49	0.92
Return on Equity (ROE)	7.59%	7.59%	8.37%	9.02%	7.55%	-
Return on Assets (ROA)	4.46%	4.46%	4.52%	4.57%	3.37%	-
Return on Invested Capital (ROIC)	10.74%	10.64%	9.18%	9.46%	6.94%	6.89%
Return on Capital Employed (ROCE)	7.70%	7.70%	8.70%	9.20%	7.00%	9.30%
Earnings Yield	3.09%	2.91%	-	-	-	-
FCF Yield	4.06%	3.83%	-	-	-	-
Payout Ratio	13.65%	13.65%	-	0.11%	5.98%	16.44%
Buyback Yield / Dilution	-6.45%	-6.77%	-	-1.76%	-3.63%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.